Last Updated on June 13, 2025
Bio-Equivalence and Bio-Availability (BE/BA) Studies
Bioequivalence studies are conducted to evaluate the difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study.
Following Bio Availability and Bio Equivalence Studies are carried out with the approval of Clinical Studies Committee:-